SCHEMBL31714850

SCHEMBL31714850

CCOC(=O)c1cn(CCOC)nc1NC(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 1/20 0.44
▸ TEAD2 Q15562 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KDM4E B2RXH2 5/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 3/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HTT P42858 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ MAP3K5 Q99683 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31715017 0.86 MAPT (0.44) IKBKBTEAD2POLBKDM4EMAPT
SCHEMBL31714691 0.82 LMNA (0.44) POLBKDM4EMAPTMAPK1TP53
SCHEMBL31714887 0.81 TEAD2 (0.43) TEAD2KDM4EALDH1A1HSD17B10KMT2A
SCHEMBL8693064 0.79 ALDH1A1 (0.52) IKBKBPOLBKDM4EMAPTALDH1A1
SCHEMBL21724143 0.78 MAP3K5 (0.45) TEAD2POLBKDM4EMAPTALDH1A1
SCHEMBL21408417 0.75 GAA (0.46) TEAD2POLBKDM4EALDH1A1HSD17B10
SCHEMBL21723835 0.75 TEAD2 (0.39) TEAD2KDM4EALDH1A1HSD17B10TSHR
SCHEMBL31715045 0.74 POLB (0.43) POLBKDM4EMAPTALDH1A1MAPK1
SCHEMBL8696094 0.74 TEAD2 (0.38) TEAD2KDM4EMAPTALDH1A1HSD17B10
SCHEMBL8696070 0.73 LMNA (0.40) TEAD2KDM4EALDH1A1MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333424-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2025-10-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333424-A1 ANTIVIRAL COMPOUNDS MAVS, EIF2AK2, IRF3 IKBKB 373/4885TEAD2 3815/4885POLB 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback